Get the Stockscreener App
21.39
1.63%
-0.355
After Hours:
21.39
Tectonic Therapeutic Inc stock is traded at $21.39, with a volume of 130.18K.
It is down -1.63% in the last 24 hours and up +36.94% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$21.75
Open:
$21.5
24h Volume:
130.18K
Relative Volume:
0.38
Market Cap:
$376.79M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.00%
1M Performance:
+36.94%
6M Performance:
-50.28%
1Y Performance:
+0.00%
1-Day Range:
$20.80
$21.99
1-Week Range:
$19.55
$21.99
52-Week Range:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
21.39 | 376.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Shares Sold by Wells Fargo & Company MN - Defense World
Geode Capital Management LLC Grows Stock Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
How did Tectonic Therapeutic Inc (TECX) fare last session? - uspostnews.com
Tectonic Announces $185 Million Private Placement - The Globe and Mail
Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Mizuho - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Increase in Short Interest - Defense World
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $77.75 - Defense World
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Mizuho Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Mizuho Initiates Tectonic Therapeutic at Outperform - marketscreener.com
Mizuho sets Tectonic stock Outperform with $51 target - Investing.com Australia
Mizuho sets Tectonic stock Outperform with $51 target By Investing.com - Investing.com India
Tectonic Therapeutic Inc (NASDAQ: TECX): Blank Check For Growth? - Stocksregister
Vanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025 - marketscreener.com
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 - GlobeNewswire
Major Breakthrough: New Phase 1b Heart Failure Drug Data Promises Key Insights at ESC 2025 - Stock Titan
Tectonic Therapeutic Insider Bought Shares Worth $2,299,015, According to a Recent SEC Filing - marketscreener.com
Raymond James Financial Inc. Takes Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Major Investment Alert: Insider Buys Big in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic director Timothy Springer acquires $2.3 million in shares - Investing.com
Commonwealth Equity Services LLC Takes $231,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Thursday 4/10 Insider Buying Report: TECX, GMS - Nasdaq
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares By Investing.com - Investing.com South Africa
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares - Investing.com Canada
Director’s Bold Move: Massive Stock Sale Shakes Tectonic Therapeutic! - TipRanks
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock By Investing.com - Investing.com South Africa
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock - Investing.com
Tectonic Therapeutic Reports Strong 2024 Financial Results - TipRanks
Charles Schwab Investment Management Inc. Invests $218,000 in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Recommendation of “Buy” from Analysts - The AM Reporter
Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Average Price Target from Brokerages - Defense World
Tectonic Therapeutic: Buy Rating Affirmed on Strong Financials and Promising Pipeline - TipRanks
Wells Fargo & Company Lowers Tectonic Therapeutic (NASDAQ:TECX) Price Target to $101.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given New $101.00 Price Target at Wells Fargo & Company - Armenian Reporter
Tectonic Therapeutic Inc. (TECX) reports earnings - Quartz
Tectonic Therapeutic Announces Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights - Marketscreener.com
Tectonic Therapeutic Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tectonic Therapeutic, Inc. SEC 10-K Report - TradingView
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic's TX45 Trial Achieves 30% Disease Reduction, Extends Runway to 2028 - StockTitan
Tectonic Therapeutic Inc expected to post a loss of $1.39 a shareEarnings Preview - TradingView
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Is Tectonic Therapeutic, Inc. (TECX) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $80.50 - Defense World
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.39%
3.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):